Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alphaton Capital Corp (ATON)

Alphaton Capital Corp (ATON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,507
  • Shares Outstanding, K 8,188
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,770 K
  • EBIT $ -12 M
  • EBITDA $ -12 M
  • 60-Month Beta 0.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -7.65
  • Most Recent Earnings N/A on 11/26/24
  • Next Earnings Date 01/06/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Finance
  • INDUSTRY GROUPING Finance - Misc Services

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5580 +43.03%
on 12/29/25
3.3000 -75.82%
on 01/13/26
-0.3019 (-27.45%)
since 12/15/25
3-Month
0.5580 +43.03%
on 12/29/25
6.6672 -88.03%
on 10/16/25
-5.7219 (-87.76%)
since 10/15/25
52-Week
0.5580 +43.03%
on 12/29/25
15.8200 -94.96%
on 04/22/25
-3.1719 (-79.90%)
since 01/15/25

Most Recent Stories

More News
Hyperscaler Market Enters a New Growth Cycle as AI and Cloud Demand Accelerate

EQNX::TICKER_START (NASDAQ:VVPR),(NASDAQ:ATON),(NYSE:ORCL),(NASDAQ:MSFT),(NASDAQ:EVTV) EQNX::TICKER_END

MSFT : 459.44 (+0.01%)
EVTV : 3.39 (+9.35%)
ORCL : 192.60 (-0.52%)
VVPR : 2.81 (-5.70%)
ATON : 0.7963 (-13.15%)
AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program

DOVER, DE, Dec. 17, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ( NASDAQ: ATON) ("AlphaTON" or the "Company"), a publicly traded technology company, issues a clarification on its previously announced...

ATON : 0.7963 (-13.15%)
AlphaTON Capital Corp Announces Intention to Launch Decentralized AI-Native Biotech Platform Focused on Rare Cancers

DOVER, DE, Dec. 17, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ( NASDAQ: ATON ), the world's leading public technology company scaling the Telegram super app, with an addressable market of 1 billion...

ATON : 0.7963 (-13.15%)
AlphaTON Capital Corp Announces Historic Strategic $30 Million Investment in Anduril Industries

WASHINGTON, D.C., Dec. 16, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ( NASDAQ: ATON ), the world's leading technology public company scaling the Telegram super app, with an addressable market...

ATON : 0.7963 (-13.15%)
AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

Dover, DE and Sydney, Australia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp  (Nasdaq: ATON ) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado...

ATON : 0.7963 (-13.15%)

Business Summary

AlphaTON Capital is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. AlphaTON Capital Corp., formerly known as Portage Biotech Inc., is based in DOVER, Del.

See More

Key Turning Points

3rd Resistance Point 1.2366
2nd Resistance Point 1.1433
1st Resistance Point 1.0301
Last Price 0.7963
1st Support Level 0.8236
2nd Support Level 0.7303
3rd Support Level 0.6171

See More

52-Week High 15.8200
Fibonacci 61.8% 9.9899
Fibonacci 50% 8.1890
Fibonacci 38.2% 6.3881
Last Price 0.7963
52-Week Low 0.5580

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar